Tagrisso 40mg Tablet
Prescription Required
Product introduction
Tagrisso 40mg Tablet is a protein kinase inhibitor used in the treatment of non-small cell lung cancer. It is used in the treatment of adult patients who have certain estimated glomerular filtration rate (EGFR) mutations.
Tagrisso 40mg Tablet is used to treat different types of cancer
Tagrisso 40mg Tablet is used to treat different types of cancer
Uses of Tagrisso Tablet
Benefits of Tagrisso Tablet
In Non-small cell lung cancer
Non-small cell lung cancer is one of the major kinds of lung cancer and it affects both smokers as well as non-smokers. Tagrisso 40mg Tablet helps treat non-small cell lung cancer and may be given alone or in combination with other medicines. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.
Side effects of Tagrisso Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Tagrisso
- Diarrhea
- Loss of appetite
- Rash
- Stomatitis (Inflammation of the mouth)
How to use Tagrisso Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Tagrisso 40mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Tagrisso 40mg Tablet. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Tagrisso 40mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Tagrisso 40mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
SAFE
Tagrisso 40mg Tablet does not usually affect your ability to drive.
Kidney
SAFE IF PRESCRIBED
Tagrisso 40mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Tagrisso 40mg Tablet is recommended.
Liver
SAFE IF PRESCRIBED
Tagrisso 40mg Tablet is safe to use in patients with liver disease. No dose adjustment of Tagrisso 40mg Tablet is recommended.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Fact Box
Chemical Class
M-Alkylindoles
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Tyrosine kinase inhibitors
Patient concerns
User feedback
What are you using Tagrisso Tablet for?
Non-small cel*
100%
*Non-small cell lung cancer
How much was the improvement?
Excellent
67%
Average
33%
What were the side-effects while using Tagrisso 40mg Tablet?
No Side Effec*
100%
*No Side Effect
How do you take Tagrisso Tablet?
With or witho*
100%
*With or without food
Please rate Tagrisso 40mg Tablet on price
Average
100%
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Medscape. Osimertinib. [Accessed 26 Mar. 2019] (online) Available from:
- Osimertinib. Luton, Bedfordshire: AstraZeneca UK Limited; 2016 [revised 31 Aug. 2018]. [Accessed 26 Mar. 2019] (online) Available from:
Marketer details
Name: AstraZeneca
Address: Corporate & Registered Office, Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Outer Ring Road, 560045, Bangalore
Country of origin: Sweden
Expires on or after: February, 2025
A licensed vendor partner from your nearest location will deliver Tagrisso 40mg Tablet. Once the pharmacy accepts your order, the details of the pharmacy will be shared with you. Acceptance of your order is based on the validity of your doctor's ℞ and the availability of this medicine.
Phone Number: 0124-4166666
Address: 5th Floor Tower - B of the Presidency Building, 46/4 Mehrauli Gurgaon Road, Sector 14, Gurugram, Haryana-122001, India
Expires on or after: February, 2025
A licensed vendor partner from your nearest location will deliver Tagrisso 40mg Tablet. Once the pharmacy accepts your order, the details of the pharmacy will be shared with you. Acceptance of your order is based on the validity of your doctor's ℞ and the availability of this medicine.
In case of any issues, contact us
Email ID: [email protected]Phone Number: 0124-4166666
Address: 5th Floor Tower - B of the Presidency Building, 46/4 Mehrauli Gurgaon Road, Sector 14, Gurugram, Haryana-122001, India
Lab tests offered by us
Related/Popular tests
98 people viewed this recently